|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/91 | |
| C07D 403/04 | |||
| C07D 403/02 | |||
| A61K 31/517 | |||
| A61K 31/519 | |||
| A61P 9/00 |
| (11) | Number of the document | 2660238 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13175561.3 |
| Date of filing the European patent application | 2010-01-08 | |
| (97) | Date of publication of the European application | 2013-11-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 143276 P | 2009-01-08 | US |
| (72) |
Hansen, C., Henrik, CA
|
| (73) |
Resverlogix Corporation,
300, 4820 Richard Road SW Calgary, AB T3E 6L1,
CA
|
| (54) | Compounds for the prevention and treatment of cardiovascular disease |
| Compounds for the prevention and treatment of cardiovascular disease |